MarketPeel
Insider Trading Intelligence
VL

Versant Side Fund Iv, L.p.

TPST
10% OWNER · TEMPEST THERAPEUTICS, INC. · CIK 0001456591
FILING MIX · LIFETIME91%/9%
BUYS
21
SELLS
2
TOTAL VALUE
$967.0K
COMPANIES
2
ACTIVE SINCE
Apr 2024
HOLDINGS NOW
644,666
AVG SELL PX
$1.23
TRADE KIND
SHOWING 23 / 23
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Versant Side Fund Iv, L.p., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+0.00%+33.59%+4.58%+29.01%+29.01%
14d2+0.00%+28.67%+4.99%+23.68%+23.68%
30d2+50.00%+18.37%+2.90%+15.47%+15.47%
60d2+0.00%+6.17%+8.17%-2.01%-2.01%
90d2+50.00%-3.72%+12.17%-15.90%-15.90%
180d2+100.00%-19.54%+13.76%-33.30%-33.30%
1y2+100.00%-43.47%+21.44%-64.90%-64.90%
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TPST · 209,941 shares · as of Aug 12, 2024
0149,485298,970448,455597,940SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
FLOW · 21 buys / 2 sellsCOVERAGE · 2 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TPST
TEMPEST THERAPEUTICS, INC.
SALE
387,999$1.10$427.0K209,941Aug 12, 2024Aug 12, 2024View →
TPST
TEMPEST THERAPEUTICS, INC.
SALE
400,000$1.35$540.0K597,940Aug 8, 2024Aug 12, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
1,423,1191,423,119Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
1,9310Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
57,5650Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
22,3120Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
391,785391,785Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
110,1871,934,776Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
1,476,4461,476,446Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
68912,123Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
317,9881,741,107Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
90,7470Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
1450Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
275,769710,494Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
148,312148,312Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
298,9750Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
9,2529,252Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
2,5312,531Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
2,18211,434Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
4550Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
70,4980Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
348,1431,824,589Apr 9, 2024Apr 11, 2024View →
CTNM
CONTINEUM THERAPEUTICS, INC.
PURCHASE
434,725434,725Apr 9, 2024Apr 11, 2024View →
Other insiders · TPST
Loading peer insiders…
About this filer
CIK 0001456591
ROLE
10% Owner
PRIMARY
TPST
COMPANIES
2
ACTIVE SINCE
Apr 2024
MARKETPEEL · /INSIDER/0001456591DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback